European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 0.81% to 1,363.17 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by accommodations booking company trivago (TRVG) and biopharmaceutical company argenx (ARGX), which rose 2.6% and 1.5% respectively. They were followed by software firm SAP (SAP) and energy company Equinor (EQNR), which were up 1.4% and 1.3% respectively.
The decliners from continental Europe were led by biopharmaceutical companies DBV Technologies (DBVT) and Genfit (GNFT), which fell 5.2% and 2.8% respectively. They were followed by biopharmaceutical company Grifol (GRFS) and furniture maker Natuzzi (NTZ), which dropped 2.2% and 0.8% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies NuCana (NCNA) and Biodexa Pharmaceuticals (BDRX), which increased 4.3% and 3% respectively. They were followed by biopharmaceutical companies TC Biopharm (TCBP) and Akari Therapeutics (AKTX), which rose 2.4% and 2.3% respectively.
The decliners from the UK and Ireland were led by biotech company Trinity Biotech (TRIB) and biopharmaceutical company Amarin (AMRN), which lost 6.4% and 3.9% respectively. They were followed by alcoholic beverage company Diageo (DEO) and pharmaceutical company Silence Therapeutics (SLN), which were down 1.8% and 1.5% respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。